vs
Side-by-side financial comparison of Atlanta Braves Holdings, Inc. (BATRA) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $61.3M, roughly 1.2× Atlanta Braves Holdings, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 17.6%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -52.5%).
Atlanta Braves Holdings, Inc. is a sports and entertainment holding company that owns and operates the Atlanta Braves MLB franchise. It also manages adjacent mixed-use real estate, live events, merchandise sales, and media operations, serving fans across the U.S. Southeast and global baseball audiences.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
BATRA vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.3M | $75.5M |
| Net Profit | $-41.4M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -81.2% | 22.7% |
| Net Margin | -67.6% | — |
| Revenue YoY | 17.6% | 27.7% |
| Net Profit YoY | -116.7% | — |
| EPS (diluted) | $-0.64 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.3M | $75.5M | ||
| Q3 25 | $311.5M | $54.5M | ||
| Q2 25 | $312.4M | $52.4M | ||
| Q1 25 | $47.2M | $46.0M | ||
| Q4 24 | $52.1M | $59.1M | ||
| Q3 24 | $290.7M | $80.5M | ||
| Q2 24 | $282.9M | $47.1M | ||
| Q1 24 | — | $43.8M |
| Q4 25 | $-41.4M | — | ||
| Q3 25 | $30.0M | $8.8M | ||
| Q2 25 | $29.5M | $5.9M | ||
| Q1 25 | $-41.4M | $3.0M | ||
| Q4 24 | $-19.1M | — | ||
| Q3 24 | $10.0M | $20.3M | ||
| Q2 24 | $29.1M | $-4.5M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -81.2% | 22.7% | ||
| Q3 25 | 12.5% | 17.6% | ||
| Q2 25 | 13.4% | 12.7% | ||
| Q1 25 | -94.2% | 8.7% | ||
| Q4 24 | -35.8% | 22.6% | ||
| Q3 24 | 2.2% | 27.4% | ||
| Q2 24 | 8.8% | -4.6% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | -67.6% | — | ||
| Q3 25 | 9.6% | 16.2% | ||
| Q2 25 | 9.4% | 11.2% | ||
| Q1 25 | -87.7% | 6.5% | ||
| Q4 24 | -36.7% | — | ||
| Q3 24 | 3.4% | 25.2% | ||
| Q2 24 | 10.3% | -9.6% | ||
| Q1 24 | — | -11.0% |
| Q4 25 | $-0.64 | $0.26 | ||
| Q3 25 | $0.47 | $0.17 | ||
| Q2 25 | $0.46 | $0.12 | ||
| Q1 25 | $-0.66 | $0.06 | ||
| Q4 24 | $-0.29 | $0.40 | ||
| Q3 24 | $0.16 | $0.41 | ||
| Q2 24 | $0.46 | $-0.09 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.9M | $97.5M |
| Total DebtLower is stronger | $738.6M | $22.7M |
| Stockholders' EquityBook value | $526.0M | $130.3M |
| Total Assets | $1.6B | $216.3M |
| Debt / EquityLower = less leverage | 1.40× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.9M | $97.5M | ||
| Q3 25 | $82.2M | $94.4M | ||
| Q2 25 | $96.2M | $96.0M | ||
| Q1 25 | $244.7M | $93.2M | ||
| Q4 24 | $110.1M | $101.0M | ||
| Q3 24 | $100.9M | $96.7M | ||
| Q2 24 | $121.2M | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | $738.6M | $22.7M | ||
| Q3 25 | $759.9M | $34.0M | ||
| Q2 25 | $703.1M | $45.3M | ||
| Q1 25 | $699.5M | $56.7M | ||
| Q4 24 | $617.1M | $68.0M | ||
| Q3 24 | $640.1M | $79.3M | ||
| Q2 24 | $600.0M | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $526.0M | $130.3M | ||
| Q3 25 | $560.3M | $115.3M | ||
| Q2 25 | $522.8M | $104.7M | ||
| Q1 25 | $486.1M | $97.1M | ||
| Q4 24 | $524.2M | $92.1M | ||
| Q3 24 | $530.4M | $71.1M | ||
| Q2 24 | $512.7M | $48.5M | ||
| Q1 24 | — | $51.0M |
| Q4 25 | $1.6B | $216.3M | ||
| Q3 25 | $1.7B | $202.9M | ||
| Q2 25 | $1.7B | $194.9M | ||
| Q1 25 | $1.7B | $196.2M | ||
| Q4 24 | $1.5B | $213.3M | ||
| Q3 24 | $1.6B | $220.7M | ||
| Q2 24 | $1.6B | $205.0M | ||
| Q1 24 | — | $214.1M |
| Q4 25 | 1.40× | 0.17× | ||
| Q3 25 | 1.36× | 0.30× | ||
| Q2 25 | 1.34× | 0.43× | ||
| Q1 25 | 1.44× | 0.58× | ||
| Q4 24 | 1.18× | 0.74× | ||
| Q3 24 | 1.21× | 1.12× | ||
| Q2 24 | 1.17× | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.4M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.4M | $14.4M | ||
| Q3 25 | $-88.8M | $9.7M | ||
| Q2 25 | $-8.1M | $14.1M | ||
| Q1 25 | $95.8M | $3.6M | ||
| Q4 24 | $28.9M | $15.6M | ||
| Q3 24 | $-69.0M | $11.0M | ||
| Q2 24 | $-34.3M | $1.0M | ||
| Q1 24 | — | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $-82.3M | $14.1M | ||
| Q1 25 | $76.3M | $3.6M | ||
| Q4 24 | $16.8M | $15.6M | ||
| Q3 24 | $-85.5M | $11.0M | ||
| Q2 24 | $-64.1M | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | -26.3% | 26.8% | ||
| Q1 25 | 161.5% | 7.7% | ||
| Q4 24 | 32.3% | 26.4% | ||
| Q3 24 | -29.4% | 13.7% | ||
| Q2 24 | -22.7% | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 23.7% | 0.0% | ||
| Q1 25 | 41.3% | 0.1% | ||
| Q4 24 | 23.2% | 0.0% | ||
| Q3 24 | 5.7% | 0.0% | ||
| Q2 24 | 10.5% | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | -2.96× | 1.10× | ||
| Q2 25 | -0.28× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.89× | 0.54× | ||
| Q2 24 | -1.18× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
PBYI
Segment breakdown not available.
